May 08, Hyderabad, India: Cigniti Technologies, a global leader in AI and IP-led Digital Assurance and Digital Engineering services, has emerged victorious in the prestigious MedTech Breakthrough Awards 2023. The company’s groundbreaking Internet of Medical Things (IoMT) Digital Quality Engineering Automation framework has clinched the coveted “Best IoT Healthcare Platform” accolade. MedTech Breakthrough, an esteemed independent market intelligence organization, organizes the annual awards program to honor top companies, technologies, and products in the global health and medical technology market.
Cigniti’s IoMT Digital Quality Engineering Automation framework revolutionizes the healthcare industry by ensuring precise medication delivery through wearables while complying with rigorous USFDA regulations. This Software as a Medical Device (SaMD) platform boasts complete automation with minimal human intervention and conducts thorough negative testing to ensure optimal performance and desired outcomes.
Expressing delight, Srikanth Chakkilam, CEO of Cigniti Technologies, emphasized their commitment to the evolving medical devices sector, where IoMT and connected devices are increasingly critical. Chakkilam stated that IoMT has the potential to reduce costs, address healthcare coordination challenges, and enhance real-time diagnosis and treatment speed and accuracy. He expressed confidence in Cigniti’s growth trajectory in the medical devices market and regarded the “Best IoT Healthcare Platform” recognition as a testament to their expertise in digital assurance for FDA-compliant medical devices.
Raghuram Krovvidy, Chief Delivery Officer of Cigniti, highlighted the significance of precision in connected devices within the healthcare realm. Krovvidy emphasized the seamless operation and utmost security of the ecosystem involving mobile apps, medical device software, healthcare CRMs, and patient database management applications. He lauded Cigniti’s Quality Engineering framework’s MedTech award as a testament to their leadership and expertise, particularly in the Software as a Medical Device (SaMD) platform.
Johnson highlighted Cigniti’s IoMT platform’s all-encompassing approach, which includes domain expertise, device knowledge, infrastructure, legislative compliance, and testing capabilities. He emphasized that Cigniti’s platform provides a one-stop solution for medical device testing, supporting the needs of the industry.
Cigniti’s IoMT lab and infrastructure have already made significant strides in the healthcare sector. Collaborating with a leading diabetes care provider, a medical devices company, and a prominent healthcare organization, Cigniti has achieved remarkable results. These partnerships have resulted in a 50% reduction in cycle time, increased automation coverage, and accelerated time-to-market, all while adhering to the stringent guidelines set forth by the USFDA.
With over 4,100 employees globally, Cigniti Technologies continues to drive digital transformation for Fortune 500 and Global 2000 enterprises across various verticals and domains. Leveraging their expertise in AI and IP-led services, Cigniti assists companies in accelerating their digital adoption and achieving market leadership.
MedTech Breakthrough, a division of Tech Breakthrough, serves as a leading platform for recognizing innovation and excellence in the medical and health technology industries. The MedTech Breakthrough Awards program highlights breakthrough healthcare companies, products, services, and individuals. Categories include Patient Experience & Engagement, Health & Fitness, Medical Devices, Clinical Administration, Connected Healthcare, Medical Data, and Healthcare Cybersecurity, among others.